Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina

NCT01425359 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

949

Enrollment

INDUSTRY

Sponsor class

Conditions

Angina Pectoris
Coronary Artery Disease
Type 2 Diabetes Mellitus

Interventions

DRUG: Ranolazine
DRUG: Ranolazine placebo

Sponsor

Gilead Sciences